A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori - Wikidata - wikimedia - TriplyDB

A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori

A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori

http://www.wikidata.org/entity/Q35532235

about

Optimum duration of regimens for Helicobacter pylori eradication Helicobacter pylori in gastric carcinogenesis Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?Rapid and sensitive determination of levofloxacin in microsamples of human plasma by high-performance liquid chromatography and its application in a pharmacokinetic study.Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy.Efficacy of microencapsulated lactic acid bacteria in Helicobater pylori eradication therapy.Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland Helicobacter pylori Eradication Therapy: Current Availabilities.A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience Review article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Helicobacter pylori: evidence-based review with a focus on immigrant populations.Efficacy of nitazoxanide to treat natural Giardia infections in dogs.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.Treatment of Helicobacter pylori infection 2012.Helicobacter pylori infection in functional dyspepsia.Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.Attempts to enhance the eradication rate of Helicobacter pylori infection Overview of the phytomedicine approaches against Helicobacter pylori.Novel anti-Helicobacter pylori therapies.Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection.Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection.Helicobacter pylori eradication in the Swedish population.Helicobacter pylori treatment: Still a work in progress.In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains.Bibliometric Assessment of the Global Scientific Production of Nitazoxanide ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen.Dealing with uncertainty in the treatment of Helicobacter pylori.Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study

P2860

Q24201841-9E0C397B-BB90-4024-A9A9-03D53F7A7BE5 Q26774101-376C3BF9-16E2-4C64-99BC-8A7A22586073 Q34067951-EF2C6085-EE38-4D0F-BA7E-E346D4A215E8 Q34255425-38F6BF11-5524-448C-94FA-9DA08B7B1EFF Q34983201-DD96CDAA-B9C3-4A32-9B88-7B4E354C2D4A Q35193051-2D7711FD-F141-4478-A11E-A43DFAE0091D Q35692337-65F64A01-A44D-469B-BE2A-8CB40AC51F18 Q35940597-068B3933-4799-4A40-A451-EDEA150E9E97 Q36010979-7B094FEE-F463-4FED-931F-8ECE6A7BBBF5 Q36148148-DCA8BA3F-955A-4420-B1BB-31F0361D7812 Q37205675-A7DCA04F-C1A3-4FFD-BCE5-7CC578BD092D Q37340339-97175F7D-8070-4584-8CD1-B32E83DA52F2 Q37378899-9643317D-FD1C-4BA4-8025-D4E0645BDBC6 Q37595765-BFCC44A1-AF30-44F0-9EE4-153F7DAF4B24 Q37618752-0D29D1F0-1722-4050-AAE0-EFF0B4A57441 Q38029324-0852A944-A2DB-4D2F-9C8A-DBEBF23CC535 Q38041644-2CF59E4C-3B4B-4A67-A2C6-0379A194FF65 Q38077448-24CE368D-73B3-48D0-BA89-A3B173F8677C Q38182087-A6043606-1A2E-41C3-B383-0DDBBFA45D44 Q38212213-761C4C46-4F08-4E1F-9010-1F8E214EC493 Q38219017-8C4136A5-8A63-4D4A-A0DE-58400489F2A8 Q38257748-ABD3FE8C-B9B5-41A7-9A6A-0760EB72D5A3 Q38373321-4A7890E2-7EA2-49EC-AF9F-0A99282815D5 Q38376587-9E25BD7F-31D1-4055-A496-A351789BEE2D Q38402111-EBF21590-A461-487C-ABDF-8C1CA1FBF662 Q38613590-3E936307-B846-40B7-9953-8D46A00A6C68 Q38650879-991E0DF7-C616-433B-8878-62AA4F2638DC Q38744585-1194CA78-7C43-447C-8D8E-549784EFAB32 Q40378087-0AA4B575-9A68-4BF2-84BD-4E57F969553D Q40941209-0410E0AC-6BB5-4A81-860C-799DBD499A13 Q41391795-863306CD-6461-42D7-A2A8-AE944DCAE77E Q41682366-3352AFD8-8F91-45E2-9168-E4B64B29AFB4 Q46049471-0BE29AD8-D79D-4E41-9E30-1F84C28ADCA7 Q47345605-8521E5A8-DB3D-498D-B07F-E01C73157412 Q52330458-CB2679AF-33EF-486D-A857-90D0ECC2195E Q57913583-8F901C91-142A-4F67-A7D1-DE07CBA9ABD5

P2860

A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori

http://www.wikidata.org/entity/Q35532235

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A randomized study comparing l ...... ication of Helicobacter pylori

@ast

A randomized study comparing l ...... ication of Helicobacter pylori

@en

type

label

A randomized study comparing l ...... ication of Helicobacter pylori

@ast

A randomized study comparing l ...... ication of Helicobacter pylori

@en

prefLabel

A randomized study comparing l ...... ication of Helicobacter pylori

@ast

A randomized study comparing l ...... ication of Helicobacter pylori

@en

P1433

Q35532235-64D632A2-F4CF-49C1-9792-C41730103EBE

P1476

Q35532235-D09E7377-DBB3-484D-9B66-6F6E73C0D469

P2093

Q35532235-3B5A280C-F06D-4004-AE96-43073F7EA480

Q35532235-583600FB-3B46-466E-BF8B-F5E5A91CFD18

Q35532235-937B8C87-975A-4032-A213-49A06CC8AF0A

Q35532235-99FBF8ED-DD27-4571-B0A1-C978B737E5DE

Q35532235-C42F1B1D-F67B-4741-8698-2E5B6BCD58BA

Q35532235-D2A1B0F1-7D66-4725-A53D-00EC7A6E17AE

P2860

Q35532235-09E55A0D-DB4C-4391-A8F6-7E4E7F741751

Q35532235-10D04509-A67E-4E6A-A874-A34EBB8AD65A

Q35532235-2F2D3D62-CC0A-4335-B58C-7C95BD8EBFEC

Q35532235-390DD089-C989-4878-B8A1-57D9864C2899

Q35532235-3A6342EB-45FB-4D8E-85DF-E1970D71A04D

Q35532235-41036A13-00AB-4DF4-ADE3-BDAAAFFB374D

Q35532235-4416E439-C2A3-494F-A385-327DDE8A8DCF

Q35532235-4804026D-659E-4478-8F01-15684BF121F3

Q35532235-4FCB3B95-F4D0-4300-B472-FD053B3DFAAF

Q35532235-54A9D072-5082-4E84-A956-F06FD299A28C

P2888

Q35532235-C9E7C137-C0D9-4341-9583-19AB60E0E34B

P304

Q35532235-A87D82D0-FEF3-4FC1-9BC2-B1269988372D

P31

Q35532235-C5C07F3F-3594-4AB7-8291-49DAEFC8F149

P356

Q35532235-F3F70EAB-82D4-4B32-A670-29A6AF3C3B01

P407

Q35532235-456D1746-FD17-46B4-B5D8-7FED4E7F8F63

P433

Q35532235-30366C95-5202-4D3E-9D91-AC9DC963979C

P478

Q35532235-B84FC195-5BB6-442E-810D-3C6C1B349E65

P577

Q35532235-7DEE2257-1D62-4184-AEA1-CD4EB2F0A14A

P5875

Q35532235-3DC02148-1C58-40CC-B438-CD588DD30D71

P6179

Q35532235-8D8817A5-6EAF-4E49-84CA-0DD8A73B6B28

P698

Q35532235-D7FD715B-A5E0-4302-A5FA-5C949842BF87

P921

Q35532235-0689F6CD-C2B7-404F-9963-0B42B50D815D

P932

Q35532235-7FBAC966-35E7-451C-8791-268F9BF81245

P356

P1433

The American Journal of Gastroenterology

P1476

A randomized study comparing l ...... ication of Helicobacter pylori

@en

P2093

Krishna Rayapudi

http://www.w3.org/2001/XMLSchema#string

Molly Flynn

http://www.w3.org/2001/XMLSchema#string

Niraj James Shah

http://www.w3.org/2001/XMLSchema#string

Nithya Krishnaswamy

http://www.w3.org/2001/XMLSchema#string

P Patrick Basu

http://www.w3.org/2001/XMLSchema#string

Tommy Pacana

http://www.w3.org/2001/XMLSchema#string

P2860

New concepts of resistance in the treatment of Helicobacter pylori infections

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori.

Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States.

The tetracyclines.

Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection.

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.

The fluoroquinolones.

American College of Gastroenterology guideline on the management of Helicobacter pylori infection.

Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.

P2888

P304

1970-1975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2011.306

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51708826

http://www.w3.org/2001/XMLSchema#string

P6179

1010102637

http://www.w3.org/2001/XMLSchema#string

P698

21989146

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

3209586

http://www.w3.org/2001/XMLSchema#string